CCS Luton Adults Tissue Viability service supported the delivery of this NIHR funded randomised control trial in 2011 - 2012, contributing 6 patients into the participant group.
Conclusions: Trial data from VenUS IV found no evidence of a difference in venous ulcer healing between HH and the 4LB. HH may reduce ulcer recurrence rates compared with the 4LB and be a cost-effective treatment. When all available high-compression treatments were considered, the 2LB had the highest probability of being clinically effective and cost-effective. However, the underpinning evidence was sparse and more research is needed. Further research should thus focus on establishing, in a high-quality trial, the effectiveness of this compression system in particular.
Read publication here for full interesting findings found from this study (RL Ashby · 2014)